| 1 |
28992765 | Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study. | 2018 Sep |
1 |
| 2 |
27539372 | CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites. | 2017 Mar |
1 |
| 3 |
27763679 | Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients. | 2017 Apr |
1 |
| 4 |
26677906 | In vitro inhibition and enhancement of liver microsomal S-777469 metabolism by long-chain fatty acids and serum albumin: insight into in vitro and in vivo discrepancy of metabolite formation in humans. | 2016 |
1 |
| 5 |
25986145 | Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors. | 2015 Jun |
1 |
| 6 |
24944083 | Identification of human cytochrome P450 isozymes involved in the metabolism of naftopidil enantiomers in vitro. | 2014 Nov |
1 |
| 7 |
23641937 | Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9. | 2013 May 29 |
2 |
| 8 |
24023924 | Distal effect of amino acid substitutions in CYP2C9 polymorphic variants causes differences in interatomic interactions against (S)-warfarin. | 2013 |
1 |
| 9 |
22270321 | Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9. | 2012 Apr |
1 |
| 10 |
22436668 | Simultaneous determination of fluoxetine and norfluoxetine enantiomers using isotope discrimination mass spectroscopy solution method and its application in the CYP2C9-mediated stereoselective interactions. | 2012 May 4 |
2 |
| 11 |
22752007 | Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver. | 2012 Oct |
1 |
| 12 |
21968795 | Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat. | 2011 Nov |
1 |
| 13 |
20429590 | Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin. | 2010 May 17 |
1 |
| 14 |
19464879 | R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9. | 2009 Jul |
1 |
| 15 |
20167000 | New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II. | 2009 Dec |
1 |
| 16 |
18576910 | Possible antiretroviral therapy-warfarin drug interaction. | 2008 Jul |
1 |
| 17 |
17960328 | Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets. | 2007 Sep |
1 |
| 18 |
16946524 | Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3. | 2006 Sep |
2 |
| 19 |
15647404 | Interaction of warfarin with drugs, natural substances, and foods. | 2005 Feb |
1 |
| 20 |
15983826 | Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin. | 2005 Jul |
1 |
| 21 |
15128047 | Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers. | 2004 Jan |
1 |
| 22 |
15742978 | Genetic polymorphisms of cytochrome P450 2C9 causing reduced phenprocoumon (S)-7-hydroxylation in vitro and in vivo. | 2004 Sep |
10 |
| 23 |
12621390 | Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients. | 2003 Mar |
1 |
| 24 |
12920163 | Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes. | 2003 Sep |
1 |
| 25 |
14641553 | Clinical relevance of genetic polymorphisms in the human CYP2C9 gene. | 2003 Nov |
1 |
| 26 |
11794436 | Major bleeding caused by warfarin in a genetically susceptible patient. | 2002 Jan |
1 |
| 27 |
12913403 | Warfarin dose adjustments based on CYP2C9 genetic polymorphisms. | 2002 Dec |
1 |
| 28 |
11213860 | Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing. | 2001 Feb |
1 |
| 29 |
10870095 | Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast. | 1999 Nov |
1 |
| 30 |
9352571 | Genetic association between sensitivity to warfarin and expression of CYP2C9*3. | 1997 Oct |
1 |
| 31 |
9526963 | Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation. | 1997 Nov 15 |
1 |
| 32 |
8886617 | Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450. | 1996 Sep |
1 |
| 33 |
7574697 | Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. | 1995 Sep 10 |
1 |
| 34 |
8333835 | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 1993 Jul 15 |
1 |